mint Analytics: Real-time data visualization and analysis in clinical trials with imaging endpoints

We talked to PD Dr. Wolfgang G. Kunz, Head of Oncological Imaging and of the Oncological Study Center at the Ludwig Maximilians University Hospital Munich, about his experience with mint Analytics, an extensive add-on of the leading radiological platform mint Lesion™.

Next to the data visualization of multiple trials, PD Dr. Kunz and his team use mint Analytics for quality control of trial site reads and for sharing the current status of trial results with oncological PIs, which provides them with an estimate of what responses can be clinically expected. PD Dr. Kunz also provides an insight into how mint Analytics has the ability to open up new avenues of single and multicentric research projects and how this can benefit other radiologists, oncologists, imaging CROs as well as sponsors.

Related Resources

Related Resources

A person looking at MRI and CT scans on a  computer

Study Discovers Overdiagnosis of Progressive Cancer in Routine Clinical Evaluations

A recent retrospective study led by Dr. Marilyn J. Siegel and her team at the Washington University School of Medicine in St. Louis has shed light on…

University Hospital Jena: Research Investigating the Viability of Accelerating Whole-Body MRI in Children and Adolescents through STIR DWI with Simultaneous Multi-Slice Excitation

This study[1] addressed the challenges of conducting WB-MRI in paediatric patients, particularly the prolonged acquisition time required for…

WUSTL: Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations

In this retrospective study utilizing the mint Lesion™ software[1], researchers found that routine clinical interpretations frequently resulted in the…